Kronos Bio, Inc. — Form D
Kronos Bio, Inc. of San Mateo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-15. The offering totals $105.0M, of which $105.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-07-15
- Form: D
- Accession: 0001437749-19-013947
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $105.0M
- Amount sold: $105.0M
- Investors: 50
- Date of first sale: 2019-07-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-344261
Issuer
- Name: Kronos Bio, Inc.
- CIK: 0001741830
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1300 S. El Camino Real, San Mateo, CA, 94402
- Phone: 212-871-7920
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Arie S Belldegrun, M.D. | Director | San Mateo, CA |
| Rebecka C Belldegrun, M.D. | Director | San Mateo, CA |
| Norbert Bischofberger, Ph.D. | Director | San Mateo, CA |
| Joshua A Kazam | Director | San Mateo, CA |
| Jacob C Loven | Director | San Mateo, CA |
| John C Martin, Ph.D. | Director | San Mateo, CA |
| Otello C Stampacchia, Ph.D. | Director | San Mateo, CA |
| David M Tanen | Director | New York, NY |
| Sean A Algeo | Executive Officer | New York, NY |
| Norbert Bischofberger, Ph.D. | Executive Officer | San Mateo, CA |
| Philip C Gutry | Executive Officer | San Mateo, CA |
| David M Tanen | Executive Officer | New York, NY |
| David M Tanen | Promoter | New York, NY |
| Christopher A Wilfong | Executive Officer | New York, NY |
Other filings by this issuer (1)
More